FIDJ is a cutting-edge, results-driven law firm that anticipates and addresses the unique challenges faced by its diverse clients, providing custom legal solutions across various industries. Whether in litigation or as legal advisors, FIDJ provides efficient and effective counsel, guiding clients through complex legal matters.

Attorneys @

Law

Experienced

FIDJ leverages the combined experience of its attorneys to provide crafted solutions to meet each client’s unique legal needs.

Results-Driven

With a proven track record for success, FIDJ stands ready for the next legal challenge.

Detail-Oriented

FIDJ’s unmatched attention to detail ensures thorough and precise legal representation for every case.

Practices

Litigation and
Arbitration

Outside General Counsel

FDA

Anti-Money
Laundering

White Collar
Defense

Senior Abuse
and Neglect

Practices

Litigation and
Arbitration

Outside General
Counsel

FDA

Anti-Money
Laundering

White Collar
Defense

Senior Abuse
and Neglect

Perspectives

Apr 09, 2025

Subrogees beware—you can be compelled to arbitrate as third-party beneficiaries to an arbitration agreement

By Miguel J. Chamorro Cases requiring non-signatories to an arbitration agreement to arbitrate are not uncommon. Cases compelling subrogees to arbitrate, not because of an insurance policy but because of […]

The glp-1 saga continues: fda ends the tirzepatide shortage: frequently asked questions

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the […]

Drug or biologic? an eli lilly lawsuit could impact weight loss drug compounders

By Nicole DeFeudis November 22, 2024 Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of popular weight loss and diabetes drugs. […]

Subrogees beware—you can be compelled to arbitrate as third-party beneficiaries to an arbitration agreement

By Miguel J. Chamorro Cases requiring non-signatories to an arbitration agreement to arbitrate are not uncommon. Cases compelling subrogees to arbitrate, not because of an insurance policy but because of […]

The glp-1 saga continues: fda ends the tirzepatide shortage: frequently asked questions

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the […]

Drug or biologic? an eli lilly lawsuit could impact weight loss drug compounders

By Nicole DeFeudis November 22, 2024 Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of popular weight loss and diabetes drugs. […]

The role of delegation clauses in motions to compel arbitration when your family member signs an arbitration agreement

It happens every so often: someone signs an agreement to arbitrate legal claims, the agreement has a solid clause delegating arbitrability issues to an arbitrator, and then a member of […]

Florida civil litigation update: major changes to the rules of civil procedure have gone into effect. practitioners must be aware of the consequences for noncompliance.

January 1, 2025, marked a historic day for Florida civil litigation as the much-anticipated sweeping changes to the Florida Rules of Civil Procedure went into effect. These changes will fundamentally […]

Lilly v. fda: two stories collide to make this glp-1 case a tale of our time

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News story about the case. Lilly’s lawsuit, filed […]

Fda issues five warning letters to makers of knockoff glp-1 drugs

On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel […]

Compounded glp-1 drugs: is the party over? these are the legal and regulatory issues for game changing weight loss products and the companies selling them

Glucagon-like peptide-1, or “GLP-1” drugs, such as Ozempic® and Mounjaro®, have exploded in popularity in the United States for weight management and the treatment of obesity. However, GLP-1 drugs were […]

Compounded glp-1 drugs: is the party over? these are the legal and regulatory issues for game changing weight loss products and the companies selling them

Author’s Note: This is an updated version of the post to our blog dated October 30, 2024. Later that day, FDA announced the resolution of Novo Nordisk’s semaglutide shortage, which […]

Law

Experienced

Results-Driven

Detail-Oriented

Practices

Litigation andArbitration

Outside General Counsel

FDA

Anti-MoneyLaundering

White CollarDefense

Senior Abuseand Neglect

Practices

Litigation andArbitration

Outside General Counsel

FDA

Anti-MoneyLaundering

White CollarDefense

Senior Abuseand Neglect

Perspectives

Subrogees beware—you can be compelled to arbitrate as third-party beneficiaries to an arbitration agreement

The glp-1 saga continues: fda ends the tirzepatide shortage: frequently asked questions

Drug or biologic? an eli lilly lawsuit could impact weight loss drug compounders

Subrogees beware—you can be compelled to arbitrate as third-party beneficiaries to an arbitration agreement

The glp-1 saga continues: fda ends the tirzepatide shortage: frequently asked questions

Drug or biologic? an eli lilly lawsuit could impact weight loss drug compounders

The role of delegation clauses in motions to compel arbitration when your family member signs an arbitration agreement

Florida civil litigation update: major changes to the rules of civil procedure have gone into effect. practitioners must be aware of the consequences for noncompliance.

Lilly v. fda: two stories collide to make this glp-1 case a tale of our time

Fda issues five warning letters to makers of knockoff glp-1 drugs

Compounded glp-1 drugs: is the party over? these are the legal and regulatory issues for game changing weight loss products and the companies selling them

Compounded glp-1 drugs: is the party over? these are the legal and regulatory issues for game changing weight loss products and the companies selling them

PRACTICE AREAS

People

PERSPECTIVES

FIRM PROFILE

Litigation and
Arbitration

Anti-Money
Laundering

White Collar
Defense

Senior Abuse
and Neglect

Litigation and
Arbitration

Outside General
Counsel

Anti-Money
Laundering

White Collar
Defense

Senior Abuse
and Neglect